Skip to main content

Table 1 Characteristics of the study population

From: Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline

Variable Overall cohort Controlled cohort (LDL-C ≤ 1.8 mmol/L) Non-controlled Cohort (LDL-C > 1.8 mmol/L)
Total Men Women Total Men Women Total Men Women
n (%) 5904 (100) 4386 (74) 1518 (26) 1759 (100) 1377 (78) 382 (22) 4145 (100) 3009 (73) 1136 (27)
LDL-C, mean (SD) mmol/L 2.2 (0.9) 2.2 (0.8) 2.3 (0.9) 1.4 (0.3) 1.4 (0.3) 1.4 (0.3) 2.5 (0.8) 2.5 (0.8) 2.6 (0.8)
Risk factors for REACH risk predictions
 Age, mean (SD) 64 (9) 63 (8) 65 (9) 64 (9) 64 (9) 64 (9) 64 (8) 63 (8) 65 (8)
 Smoking´(%) 13 12 15 13 12 15 13 12 15
 Diabetes mellitus (%) 25 24 27 31 30 34 23 22 25
 BMI < 20 kg/m2 (%) 2 1 4 2 1 4 2 1 3
 Number of vascular beds affected 1.1 1.1 1.1 1.1 1.0 1.1 1.1 1.1 1.1
 One vascular bed affected (%) 95 95 95 95 96 94 95 95 95
 Two vascular beds affected (%) 5 5 5 5 4 6 5 5 5
 Congestive heart failure (%) 2 2 2 3 3 3 2 2 2
 Atrial fibrillation (%) 3 3 3 4 4 4 3 3 2
 Statin treatment (%) 92 93 88 99 99 99 89 91 85
 Acetylsalicylic acid treatment (%) 92 93 90 93 93 94 92 93 89